Eli Lilly & Co. (LLY)
1058.18
+37.34
(+3.66%)
USD |
NYSE |
Feb 06, 16:00
1073.00
+14.82
(+1.40%)
Pre-Market: 07:00
Eli Lilly EPS Diluted (Quarterly) : 7.390 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 2.45 |
| Biogen, Inc. | -0.3333 |
| Gilead Sciences, Inc. | 2.434 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Viking Therapeutics, Inc. | -0.8083 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 6.636B |
| Revenue (Quarterly) | 19.29B |
| Total Expenses (Quarterly) | 12.66B |
| Enterprise Value | 979.74B |
| Gross Profit Margin (Quarterly) | 83.16% |
| Profit Margin (Quarterly) | 34.40% |
| Earnings Yield | 2.17% |
| Operating Earnings Yield | 3.12% |
| Normalized Earnings Yield | 2.38 |